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Abstract
The three enzymes that constitute the de novo thymidylate synthesis pathway in mammals, cytoplasmic serine
hydroxymethyltransferase (SHMT1), thymidylate synthase (TYMS) and dihydrofolate reductase (DHFR) undergo sumoylation
and nuclear import during S-phase. In this study, we demonstrate that purified intact mouse liver nuclei convert dUMP to
dTMP in the presence of NADPH and serine. Neither nuclear extracts nor intact nuclei exposed to aminomethylpho-
sphonate, a SHMT inhibitor, exhibit thymidylate synthesis activity. Nuclei isolated from Shmt1
2/2 mouse livers retained 25%
of thymidylate synthesis activity exhibited by nuclei isolated from wild type mice. This residual activity was due to the
presence of a cytoplasmic/nuclear isozyme of SHMT encoded by Shmt2. Shmt2 is shown to encode two transcripts, one
which encodes a protein that localizes exclusively to the mitochondria (SHMT2), and a second transcript that lacks exon 1
and encodes a protein that localizes to the cytoplasm and nucleus during S-phase (SHMT2a). The ability of Shmt2 to encode
a cytoplasmic isozyme of SHMT may account for the viability of Shmt1
2/2 mice and provide redundancy that permitted the
expansion of the human SHMT1 L474F polymorphism that impairs SHMT1 sumoylation and nuclear translocation.
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Introduction
Tetrahydrofolate (THF) is a metabolic cofactor that carries and
activates single carbons for the synthesis of nucleotides and
methionine [1]. Folate-mediated one-carbon metabolism is
compartmentalized in the mitochondria and cytoplasm of
eukaryotic cells (Figure 1). In the cytoplasm, this metabolic
network is required for the biosynthesis of purines, thymidylate,
and the remethylation of homocysteine to form methionine. Serine
is a major source of one-carbon units for this network through its
reversible and tetrahydrofolate-dependent conversion to glycine
and methyleneTHF catalyzed by serine hydroxymethyltransferase
(SHMT). There are cytoplasmic and mitochondrial SHMT
isozymes. SHMT1 encodes the cytoplasmic isozyme (SHMT1)
and SHMT2 encodes the mitochondrial isozyme (SHMT2) [2,3,4].
Mitochondrial one-carbon metabolism generates one-carbons
from serine through the activity of SHMT2, and the one-carbon
is oxidized and exported to the cytoplasm as formate, supporting
cytoplasmic one-carbon metabolism [5]. The SHMT1 enzyme
generates methyleneTHF for thymidylate and methionine biosyn-
thesis, but isotope tracer studies indicate that SHMT1 preferen-
tially partitions methyleneTHF to thymidylate biosynthesis [6].
The de novo thymidylate biosynthesis pathway requires three
enzymes: thymidylate synthase (TYMS), dihydrofolate reductase
(DHFR), and SHMT1. MethyleneTHF generated by SHMT is
the one-carbon donor for the TYMS catalyzed conversion of
dUMP to dTMP generating dihydrofolate (DHF). DHFR
catalyzes the NADPH-dependent reduction of DHF to regenerate
THF for subsequent cycles of de novo thymidylate synthesis.
Recently, the enzymes that constitute the thymidylate synthesis
cycle were shown to undergo post-translational modification by
the small ubiquitin-like modifier (SUMO) and nuclear transloca-
tion during S and G2/M phases [7,8]. Although the synthesis of
thymidylate in the nucleus has never been demonstrated, others
have found folate cofactors present in liver nuclei [9], and multi-
enzyme complexes containing ribonucleotide reductase and
thymidylate synthase have been isolated from nuclear extracts
[10]. In this study, intact nuclei are shown to catalyze the
formation of dTMP from dUMP, which accounts for the results of
stable isotope studies that indicate SHMT preferentially partitions
methyleneTHF to thymidylate biosynthesis. Furthermore, both
Shmt1 and Shmt2 are shown to contribute to nuclear de novo
thymidylate biosynthesis.
Results
Shmt1 and Shmt2 contribute to nuclear dTMP biosynthesis. The
ability of purified nuclei to catalyze the formation of tritiated
dTMP from unlabeled dUMP, NADPH and [2,3-
3H]-L-serine in
vitro was investigated (Figure 2). Intact nuclei isolated from the livers
of wild type mice were capable of generating tritiated dTMP,
demonstrating that folate-dependent nuclear dTMP synthesis
occurs in liver. The addition of the SHMT inhibitor and amino
acid analog, aminomethylphosphonate, to the reaction mixture
inhibited dTMP synthesis by greater than 95%, demonstrating the
essentiality of the SHMT reaction in generating folate-activated
one-carbons from serine for dTMP synthesis in nuclei. 5-
formyltetrahydrofolate pentaglutamate, a natural inhibitor of
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5839SHMT [11], did not inhibit nuclear dTMP biosynthesis but may
not have been able to traverse the nuclear membrane. Disruption
of nuclei by sonication eliminated all dTMP synthesis activity,
indicating that cytoplasmic contamination was not responsible for
the observed dTMP synthesis activity in nuclei, and suggesting
that maintenance of nuclear architecture is essential for nuclear
dTMP synthesis.
Surprisingly, intact nuclei isolated from the liver of Shmt1
2/2
mice were capable of generating tritiated dTMP at approximately
25% of the level observed from nuclei isolated from Shmt1
+/+ mice
(Figure 2). Aminomethylphosphonate inhibited dTMP synthesis in
nuclei generated from Shmt1
2/2 mice, indicating that a second
SHMT activity is present in nuclei which is not derived from
Shmt1. PCR was used to confirm the genotype of the purified
nuclei and immunoblotting was performed to verify that the nuclei
lacked Shmt1 (Figure 3A). Furthermore, the nuclei were shown to
be free of cytosolic and mitochondrial contamination (Figure 3B).
DHFR and TYMS protein were observed in purified nuclei
isolated from the livers of wild type and Shmt1
2/2 mice, and
surprisingly, SHMT2 protein was also observed in nuclei isolated
from the livers of wild type and Shmt1
2/2 mice (Figure 3A).
Previous evidence suggests that Shmt2 contains two translation
initiation sites. Expression of a SHMT2 gene fragment lacking
exon 1 in glyA CHO cells, which lack SHMT2 activity, rescued the
Figure 1. Compartmentation of folate-mediated one-carbon metabolism in the cytoplasm, mitochondria and nucleus. One-carbon
metabolism in the cytoplasm is required for the de novo synthesis of purines and thymidylate, and for the remethylation of homocysteine to
methionine. One-carbon metabolism in mitochondria generates one-carbon units for cytoplasmic one-carbon metabolism by generating formate
from serine and glycine. One-carbon metabolism in the nucleus synthesizes dTMP from dUMP and serine. SHMT2, mitochondrial serine
hydroxymethyltransferase; SHMT1, cytoplasmic serine hydroxymethyltransferase; TYMS, thymidylate synthase; DHFR, dihydrofolate reductase; THF,
tetrahydrofolate.
doi:10.1371/journal.pone.0005839.g001
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initiation start site and most of the peptide sequence required for
efficient import into mitochondria. Shmt2 contains a potential
second translation initiation codon within exon 2, and translation
initiation from this site generated a protein capable of import into
mitochondria, albeit at lower efficiency (Figure 4) [4]. To
determine if two transcripts were generated from Shmt2, one
containing exon 1 and one lacking exon 1, the mouse EST
database was probed for Shmt2 cDNA sequences that contained
nucleotide sequence from the Shmt2 intron 1/exon 2 boundary. An
EST (AA793217) that lacked exon 1 but contained 166 nucleotides
from the 39 end of intron 1 at its 59 end was identified. Similarly,
the human EST database was probed and two SHMT2 transcripts
containing 131 nucleotides from the 39 end of intron 1 were
identified (DB184899 and DA597551). These data indicate that
SHMT2 encodes two transcripts and an alternative promoter
within intron 1.
Subcellular localization of SHMT2 gene products
The cellular localization of the two SHMT2 isoforms was
determined by expression of SHMT-yellow fluorescent protein
(YFP) and red fluorescent protein (RFP) fusion proteins. Cyan
fluorescent protein fused to a mitochondrial leader sequence (CFP-
mito) at its amino terminus and Draq5 DNA binding dye were
used as mitochondrial and nuclear markers respectively. Confocal
microscopy revealed that the SHMT protein expressed from the
SHMT2 transcript containing exon 1 (referred to as SHMT2-YFP)
and CFP-mito protein co-localized to mitochondria. However,
SHMT protein expressed from the SHMT2 transcript lacking
exon 1 (referred to as SHMT2a-RFP) localized predominantly to
the cytoplasm and nucleus (Figure 5A). The nuclear localization of
the SHMT2a-RFP fusion protein exhibited similar cell cycle
dependence as observed for SHMT1 [8]. The SHMT2a-RFP
fusion protein localized exclusively to the cytoplasm in G1 phase
whereas in S and G2/M phases it localized to both the cytoplasm
and nucleus (Figure 5B).
Both SHMT2 and SHMT2a rescue the glycine auxotrophy
in GlyA Chinese Hamster Ovary cells
Previously, transfection of a human SHMT2 gene fragment that
lacked exon 1 into CHO GlyA cells, which lack SHMT2 activity in
mitochondria and exhibit a glycine auxotrophy, resulted in very
low levels of SHMT2 activity in mitochondria which was sufficient
to rescue the glycine auxotrophy [4]. In this study, the ability of
SHMT2a to rescue the glycine auxotrophy in GlyA cells was
determined. Twelve to fifteen stable transfectants were selected for
G418 resistance from GlyA cells electroporated with either an
empty TagRFP-N plasmid, a plasmid expressing the cDNA
encoding SHMT2, or a plasmid expressing the cDNA encoding
SHMT2a. All plasmids were driven by the immediate early
promoter of cytomegalovirus. Stable transfectants containing the
RFP empty vector did not rescue glycine auxotrophy and no
revertants were observed in the 12 colonies screened. However,
the glycine auxotrophy was rescued in all selected cell lines
expressing either the SHMT2-RFP or the SHMT2a-RFP fusion
protein (Figure 6). This data confirms that SHMT2a localizes to
mitochondria and can rescue mitochondrial one-carbon metabo-
lism.
Expression of SHMT2 and SHMT2a in mouse tissues
The relative levels of each SHMT2 isoform was determined in
mouse liver and kidney by western blot analyses (Figure 7). A
single immunoreactive band that migrated at 53 kD was present in
nuclear extracts isolated from mouse liver when probed with an
antibody against SHMT2. This molecular mass corresponds to the
predicted size of the SHMT2a protein expressed from the Shmt2
transcript lacking exon 1. Purified liver mitochondrial extracts
exhibited three immunoreactive bands. The upper band, which
migrated with a molecular mass of approximately 56 kDa, is
consistent with the predicted mass of the full length SHMT2 pre-
processed protein. A lower band, which migrated with a molecular
mass of approximately 50 kDa, corresponds to the processed
SHMT2 protein lacking its leader sequence as present in
mitochondria. These 3 bands were also observed in whole liver
extract, and the blot indicates that the predominant SHMT2
isoform is the processed mitochondrial form. However, a
substantial amount of the SHMT2a protein was also present in
liver. In kidney, only the pre-processed SHMT2 and SHMT2a
form of the enzyme were observed.
A single nucleotide polymorphism in SHMT1 impairs
nuclear localization
Previously, we demonstrated that a common polymorphism in
SHMT1, L474F impairs SUMO modification of the SHMT1
protein [8]. To determine if this polymorphism impairs nuclear
localization and to explore the potential for the redundancy
between SHMT1 and SHMT2a, MEFS derived from Shmt1
2/2
mice were electroporated with plasmids that express the wild-type
human SHMT1-YFP fusion protein, the human L474F SHMT1-
YFP fusion protein or a mutated K38R/K39R SHMT1-YFP
fusion protein, which lacks a SUMO-modification site [8]. MEFs
isolated from Shmt1
2/2 mice were used to eliminate the possibility
Figure 2. Thymidylate biosynthesis occurs in purified nuclei.
Liver nuclei were isolated from SHMT1
+/+ and SHMT1
2/2 mice and
capacity to convert dUMP and [2,3-
3H]-L-serine to [
3H]dTMP was
determined in reactions that contained: 1) sonicated nuclei; 2) intact
nuclei; 3) intact nuclei with 200 mM 5-CHOTHFGlu5; and 4) intact nuclei
with 100 mM aminomethyl phosphonate (AMPA). De novo thymidylate
biosynthesis activities were normalized to activity generated from
SHMT1
+/+ intact nuclei which was given an arbitrary value of 1.0.
Reactions containing sonicated nuclei contained no activity. All
reactions were performed in duplicate and the experiment repeated
twice. Variation is expressed as the standard deviation.
doi:10.1371/journal.pone.0005839.g002
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the human SHMT1 fusion proteins thereby allowing nuclear
import. The SHMT1-YFP fusion protein localized to both the
cytoplasm and nucleus in S-phase, whereas the K38R/K39R
SHMT1-YFP fusion protein localized exclusively to the cytoplasm
in S-phase (Figure 8). The L474F SHMT1-YFP fusion protein was
found in both the cytoplasm and nucleus at S-phase, but in
contrast to the SHMT1-YFP protein, its localization was primarily
cytoplasmic. These data demonstrate that the SHMT1 L474
polymorphism impairs nuclear localization. The potential for
functional redundancy between SHMT1 and SHMT2a in nuclear
folate metabolism may have been the permissive factor that
allowed this mutation to expand in human populations.
Discussion
The results from this study demonstrate directly the existence of
nuclear thymidylate biosynthesis. Pardee and co-workers
[10,12,13] first proposed the concept of nuclear nucleotide
biosynthesis and put forward the concept of a nuclear multi-
enzyme complex termed the replitase, which synthesized nucle-
otides at the replication fork during DNA synthesis. Both DHFR
and TYMS activities were found in these purified complexes
isolated from nuclei, but no direct evidence for nuclear nucleotide
biosynthesis was reported. The concept of nuclear folate
metabolism is also supported by early studies that demonstrated
10% of the total cellular hepatic folate was present within the
Figure 3. Identification of SHMT2 in purified nuclei. Panel A) PCR was used to confirm the genotype of nuclei isolated from SHMT1
+/+ and
SHMT1
2/2 mice. SHMT1
2/2 mice were generated through deletion of exon 7 which encodes the PLP binding site. SHMT1
+/+ mice exhibit a 740-bp
PCR product whereas the SHMT1
2/2 mice exhibit a 460-bp PCR product. Western blotting confirmed the presence of TYMS and DHFR in nuclei of
both genotypes. SHMT1 was present in purified liver nuclei from SHMT1
+/+ mice, but absent in liver nuclei from SHMT1
2/2 mice. SHMT2 was present
in nuclei from both genotypes. Panel B) Western blots confirm the purity of the isolated liver nuclei. The control lane represents purified cytosol from
NIH/3T3 cells for both the Lamin A (nuclear marker) and GAPDH (cytoplasmic marker). The control for the COX IV immunoblot represents a purified
mitochondrial fraction from NIH/3T3 cells. The absence of GAPDH and COX IV in nuclear extracts indicated that no cytosolic or mitochondrial
contamination was present in the nuclear thymidylate biosynthetic assays.
doi:10.1371/journal.pone.0005839.g003
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the nucleus at S-phase [8,14], and recently SHMT1, DHFR, and
TYMS proteins have all been shown to be SUMOylated,
providing a mechanism by which all the enzymes required for de
novo thymidylate biosynthesis can be localized to the nucleus [7,8].
Recent evidence indicates that nuclear folate-dependent nucleo-
tide biosynthesis is limited to thymidylate biosynthesis, as the
multi-enzyme complex responsible for de novo purine biosynthesis,
the purineosome, localizes to the cytoplasm [15].
In this study, we demonstrated that one-carbon units generated
from serine are used for nuclear de novo thymidylate biosynthesis,
and that the three enzymes that participate in de novo thymidylate
pathway are present in nuclei. Compartmentalization of these
enzymes to the nucleus accounts for previous isotope tracer studies
that demonstrate SHMT1 preferentially shuttles one-carbon units
towards thymidylate biosynthesis [6].
The data also demonstrate functional redundancy between
Shmt1 and Shmt2 in nuclear folate metabolism. The observation
that Shmt2 (and human SHMT2) encodes a nuclear/cytoplasmic
isozyme, SHMT2a, may account for the unexpected viability of
Shmt1
2/2 mice, and potentially the emergence in human
populations of the L474F SHMT1 polymorphism, which impairs
nuclear SHMT1 import. However, SHMT2a cannot fully replace
SHMT1 function as Shmt1
2/2 mice exhibit elevated uracil content
in DNA [16]. The S-phase and G2/M phase dependence of
SHMT2a nuclear localization suggests that it is available for de
novo thymidylate biosynthesis during DNA synthesis and repair as
observed for SHMT1 [8]. The mechanism by which SHMT2a
localizes to the nucleus is currently under investigation.
To our knowledge, SHMT2 is the only gene identified that
encodes proteins that can localize to the cytoplasm, nucleus and
mitochondria. Previously, zebrafish SHMT2 protein was shown to
localize exclusively to mitochondria [17]. The zebrafish Shmt2
gene lacks the second translation initiation site in exon 2 and thus
can only encode a mitochondrial isozyme. Mammalian SHMT2
genes, with the exception of the lagomorph gene, encode a
Figure 4. The mouse Shmt2 encodes two transcripts and contains two translation initiation sites. The SHMT2 transcript is denoted by the
color red. The first nucleotide of the translation initiation site contained in exon 1 is numbered as +1. The first translation initiation site in exon 1,
which encodes for the mitochondrial leader sequence, is boxed in blue. The mitochondrial leader sequence is cleaved co-translationally in the
mitochondria denoted by the scissors [2]. The second translation initiation site, present in exon 2, is boxed in blue. A transcription start site in intron 1
deduced from a mouse liver EST (AA793217) is denoted by the arrow and starts at 2166 from the second ORF.
doi:10.1371/journal.pone.0005839.g004
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cytoplasmic/nuclear SHMT2a isozyme. These data also provide
evidence for tissue-specific expression of the SHMT2 isoforms. The
SHMT2/SHMT2a ratio differs between liver and kidney, with
SHMT2 being the predominant form in liver, whereas only the
SHMT2a and the SHMT2 unprocessed protein precursor were
observed in kidney. Mitochondria are a primary source of one-
carbon units for cytoplasmic one-carbon metabolism through the
activity of SHMT2, and the SHMT2a protein lacks most of the
mitochondrial targeting sequence and may not be imported into
mitochondria efficiently [4]. Therefore, the lack of processed
SHMT2 protein in kidney mitochondria may account for previous
findings that glycine catabolism through the mitochondrial glycine
cleavage system is a major source of one-carbon units in kidney [18].
The molecular mechanisms underlying the differential promoter
usage in SHMT2 that results in the synthesis of the SHMT2 isoforms
is currently under investigation.
Compartmentation of SHMT2a and the other de novo
thymidylate biosynthetic pathway enzymes in the nucleus may
allow for folate dependent dTTP biosynthesis directly at the
replication fork. It is likely that nuclear thymidylate synthesis
requires the formation of an enzyme complex, as sonicated nuclei
were not capable of dTMP biosynthesis. It has been shown that
the processivity factor PCNA interacts with SHMT1 in both C.
elegans and HeLa cDNA yeast two hybrids [8,19]. Additional
studies are required to determine why thymidylate biosynthesis,
unlike purine nucleotide biosynthesis [15], occurs in the nucleus
and if a thymidylate-specific replitase-like complex exists that
enables the de novo dTMP synthesis pathway to function at the
replication fork and prevent uracil misincorporation into DNA.
Materials and Methods
Nuclear thymidylate biosynthesis assay
The generation and characterization of SHMT1
2/2 mice has
been described previously [16]. All study protocols were approved
by the Institutional Animal Care and Use Committee of Cornell
University and conform to the NIH Guide for the Care and Use of
Figure 5. SHMT2a localizes to the cytoplasm and nucleus. HeLa cells were transfected with cDNAs encoding SHMT2-YFP, mito-CFP, and
SHMT2a-RFP. A) The SHMT2-YFP fusion protein expressed in HeLa cells localizes to mitochondria. The mitochondrial marker, mito-CFP has a similar
localization pattern as that of SHMT2. The SHMT2a-RFP fusion protein expressed in HeLa cells localizes to both the cytoplasm and the nucleus. B)
SHMT2a-RFP localizes to the nucleus in a cell cycle dependent manner during S-phase and G2/M, whereas it is absent from the nucleus in G1 phase.
doi:10.1371/journal.pone.0005839.g005
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+/+ or
Shmt1
2/2 mice on a 129SvEv background and placed immediately
in cold phosphate buffered saline at 5uC. Liver extracts from six
age-matched males and females were combined and used for each
genotype group. Nuclei were prepared using an iodixanol gradient
as previously described [20]. Purified nuclei were suspended in
500 mL of nuclear assay buffer containing 5 mM NADPH
(Sigma), 100 mM b-mercaptoethanol, 25 mM HEPES, pH 7.5,
50 mM Sucrose, 5 mM MgCl2, 25 mM KCl, and 1 mM dUMP
(Sigma) and quantified using a hemocytometer. 125 mL of assay
buffer containing suspended nuclei were aliquoted into four 1.5 ml
plastic tubes and 8 mCi of [2,3-
3H]-L-Serine (Moravek Biochem-
icals) was added to each tube. The assay was conducted under 4
different experimental conditions: Experiment 1, nuclei that were
lysed with sonication (Branson Sonifier 150) at 5uC using two
10 sec pulses at 10 watts separated by a 10 sec resting interval;
experiment 2, intact nuclei; experiment 3, intact nuclei with 5-
formyltetrahydrofolate pentaglutamate (Schirks Laboratory) added
to at a final concentration of 200 mM; experiment 4, intact nuclei
with aminomethylphosphonate added to a final concentration of
100 mM (Sigma). Reactions were incubated for 12 h at 37uC with
shaking at 300 rpm. Nuclei were pelleted by centrifugation at
2000 rpm for 5 min and the supernatant was collected and
analyzed for radiolabeled thymidylate by high performance liquid
chromatography (HPLC). Sample preparation and HPLC was
performed as previously described [21,22]. Fractions were
collected and tritium quantified with a scintillation counter. The
retention times of [2,3-
3H]-L-serine (9 min) and
3H-thymidine
(17 min) (Moravek Biochemicals) were verified prior to separation
of the reaction mixtures. All experiments were performed in
duplicate.
Genotyping and immunoblotting
After completion of the nuclear thymidylate biosynthesis
reactions, pelleted nuclei were genotyped and analyzed by western
blots. DNA was isolated using the DNeasy Blood and Tissue Kit
(Qiagen) per manufacturer’s protocol and genotyping as previ-
ously described to confirm the Shmt1 genotype [16]. For western
Figure 6. SHMT2 and SHMT2a rescue the glycine auxotrophy in
CHO glyA cells. CHO glyA cells were transfected with cDNAs encoding
human SHMT2-RFP, SHMT2a2RFP, and a RFP-empty vector control.
Stable cells lines were selected for G418 resistance in the presence of
200 mM glycine. For growth assays, cells were cultured with and
without glycine and MTT assays were used to quantify growth. Twelve
independent lines were assayed per transfection and experiments were
done in triplicate. All values are normalized to RFP-empty vector
transfectants. There was no significant difference in growth among the
cells transfected with SHMT2 and SHMT2a with or without glycine. RFP-
empty vector transfectants with and without glycine are shown as a
circle and open box respectively. SHMT2-RFP transfectants with and
without glycine are shown as a closed box and triangle respectively.
SHMT2a2RFP transfectants with and without glycine are shown as an
inverted triangle and diamond respectively.
doi:10.1371/journal.pone.0005839.g006
Figure 7. SHMT2 and SHMT2a are present in mouse tissues. Immunoblots using a sheep-anti-human SHMT2 antibody revealed the presence
of three immunoreactive bands. Protein masses were determined by the migration distance and relative mobility of standards. Purified liver nuclei,
whole liver and whole kidney extracts contained an immunoreactive band at ,53 kDa, the predicted mass of SHMT2a. Purified liver mitochondria,
whole liver and whole kidney extracts contained a band at ,56 kDa, the predicted mass of the SHMT2 pre-processed protein. Purified liver
mitochondria and whole liver, but not whole kidney extracts contained a band at ,50 kDa, the predicted mass of the SHMT2 processed protein. The
nuclear fraction was free of cytosolic and mitochondrial contamination as shown by the GAPDH and COX IV immunoblots.
doi:10.1371/journal.pone.0005839.g007
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buffer for 10 min and protein concentrations quantified by the
Lowry-Bensadoun assay [23]. 20 mg of protein were loaded into
each lane of a 10% SDS-PAGE gel[23]. Protein transfers, western
blotting and DHFR and TYMS detection were performed as
previously described [7]. SHMT1 and SHMT2 detection were
completed as previously described [24,25]. Equal loading and/or
purity of nuclear fractions was confirmed through the detection of
GAPDH using a-GAPDH (Novus Biologicals, 1:20000 dilution),
Lamin A using a-Lamin A (Santa Cruz Biotechnology, 1:500
dilution), and COX IV using a-COX IV (Abcam, 1:5000
dilution). For Lamin A detection, goat anti-rabbit IgG-horseradish
peroxidase-conjugated secondary (Pierce) was used at a1:20000
dilution. For COX IV and GAPDH detection, a 1:10000 dilution
of goat anti-mouse IgG-horseradish peroxidase-conjugated sec-
ondary (Pierce) was used.
The sizes of the SHMT2a isoforms were determined using the
Precision Plus Protein All Blue (BIORAD) and Kaleidoscope
Prestained Standard (BIORAD). Processed mitochondrial
SHMT2 migrated with the Precision Plus Protein All Blue
50 kDa marker. To determine the size of the bands corresponding
to preprocessed SHMT2 and SHMT2a proteins, a standard curve
was generated by measuring the migration distances of the protein
standards. These distances were plotted as a function of log10 of
the molecular mass standards, and the molecular mass of
preprocessed SHMT2 and SHMT2a were determined using the
equation MM=21.4D+137.9; R
2=0.98, where MM is molecular
mass in kDa and D is migration distance in mm. The migration
distance of the largest molecular mass band corresponding to
preprocessed SHMT2 migrated 58 mm and SHMT2a migrated
61 mm, corresponding to approximately 56 kDa and 53 kDa
respectively.
Identification of Shmt2a expression
The nucleotide sequences of the human SHMT2 and mouse
shmt2 intron 1/exon 2 boundaries were BLASTED against both
the human and mouse EST databases to identify alternative
SHMT2 and Shmt2 transcripts lacking sequence encoded by exon 1
but containing intron 1 sequence within the 59-untranslated
region. To identify shmt2 protein products expressed from
alternative shmt2 transcripts, liver and kidney were isolated from
SHMT1
+/+ mice on a C57Bl/6 background. The tissues were
washed with phosphate-buffered saline and proteins solubilized
using the Mammalian Protein Extraction Reagent (Pierce)
containing 10 mM b-mercaptoethanol and a 1:100 dilution of
mammalian protease inhibitor (Sigma). Immunoblotting was
performed as described above.
Cell lines and culture
HeLa cells (CCL2) and NIH/3T3 cells (CRL-1658) were
obtained from ATCC. Mouse embryonic fibroblasts were isolated
and maintained as previously described [8]. GlyA, a CHO cell
mutant lacking SHMT2 activity, was obtained from Dr. Larry
Thompson, Lawrence Livermore Labs. All cells were cultured at
37uC in a 5% CO2 atmosphere. HeLa cells were maintained in
minimal essential medium (a-MEM) (Hyclone) with 10% fetal
bovine serum (Hyclone) and penicillin/streptomycin (Gibco). NIH/
3T3 cells were cultured in DMEM (Gibco) supplemented with 10%
fetal bovine serum and penicillin/streptomycin. GlyA cells were
cultured in DMEM supplemented with 10% dialyzed and charcoal
treated fetal bovine serum (dDMEM), 20 nM leucovorin (Sigma),
200 mM glycine (Sigma), and penicillin/streptomycin.
Subcellular localization of SHMT2 and SHMT2a
The human SHMT2 full length open reading frame was
purchased from Open Biosystems. The cDNAs for the full length
transcript (encoding SHMT2), and the transcript lacking exon 1
but containing 131 nucleotides of intron 1 in the 59UTR (encoding
SHMT2a) were amplified by PCR amplified and cloned into
PhiYFP-N (Evrogen) and TagRFP-N (Evrogen) vectors respec-
tively. The forward primer used to amplify the SHMT2 transcript
was 59-ATATCTCGAGATGCTGTACTTCTCTTTGTT-39.
The forward primer to amplify the SHMT2a transcript was
59-ATATCTCGAGGTATGGCCATTCGGGCTCAGCAC-39.
The underlined sequence signifies a XhoI (Promega) restriction site.
The same reverse primer was used for both amplifications: 59-
ATATAAGCTTCTAATGCTCATCAAAACCAG-39. The un-
derlined sequence denotes a HindIII (Promega) restriction site. The
PCR conditions for amplification of both the SHMT2 and
SHMT2a transcripts were as follows: 95uC for 45 s, 52uC for
45 s, and 72uC for 2 min. A vector containing a mitochondrial
marker, pTagCFP-mito (Evrogen) was used for control transfec-
tions to identify mitochondria. Plasmids were transfected into
HeLa cells using Lipofectamine 2000 (Invitrogen) per manufac-
turer’s protocol. The DNA binding dye, Draq5 (Biostatus Limited)
was used to visualize nuclei. For cell cycle analysis, HeLa cells
were treated with 1 mM hydroxyurea, 30 mM Lovastatin or
60 ng/ml nocodazole to block at S, G1 and G2/M phase
Figure 8. The L474F polymorphism in SHMT1 impairs nuclear localization. SHMT1
2/2 MEF cells were transfected with cDNAs encoding the
YFP-empty vector, YFP-SHMT1 wild-type, YFP-SHMT1-K38R/K39R, and YFP-SHMT1-L474F. S-phase blocked transfectants showed that YFP-SHMT1 is
greatly increased in the nucleus in S-phase. Empty vector control and K38R/K39R mutation eliminated nuclear localization, and the L474F
polymorphism inhibited nuclear localization.
doi:10.1371/journal.pone.0005839.g008
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microscopy (Leica TCS SP2 system) was used to image all cells at
the Cornell Microscope and Imaging Facility.
Rescue of the glycine auxotrophy in GlyA cells
GlyA cells were cultured in dDMEM supplemented with
200 mM glycine and 20 nM leucovorin. TagRFP-N-SHMT2 and
TagRFP-N-SHMT2a and TagRFP-N vectors were linearized
using NheI (Promega) and electroporated into GlyA cells as
previously described [26]. Following electroporation, cells were
plated on BD Primaria 100620 mm culture dishes (BD Biosci-
ence) containing 10 ml of dDMEM medium, supplemented with
20 nM leucovorin, 200 mM glycine and 200 mg/ml Geneticin
(Gibco). 12–15 colonies from each transfection were isolated and
plated in 6-well plates (Corning) containing 3 ml dDMEM
medium supplemented with glycine, leucovorin, and Geneticin.
Cell growth assays were completed in media with and without
glycine as previously reported [27].
Site-directed mutagenesis and subcellular localization of
SHMT1
The SHMT1 cDNA [28] was used as a template to generate
SHMT1-YFP fusion proteins. The SHMT1 cDNA was amplified
for cloning into PhiYFP-N by PCR. The forward and reverse
primers used were 59- ATATCTCGAGATGACGATGCCAGT-
CAAC-39 and 59-ATATAAGCTTTTAGAAGTCAGGCAGG-
CC-39 respectively. The PCR conditions were as follows: 95uC for
45 s, 55uC for 45 s, and 72uC for 2 min. The underlined regions
depict XhoI and HindIII restriction sites respectively. Coding
mutations K38R/K39R and L474F mutations were made as
previously described [8]. PhiYFP-N vectors containing the
SHMT1 cDNA, the SHMT1 cDNA containing a K38R/K39R
mutation, and a SHMT1 cDNA containing the L474F mutation
were transfected into Shmt1
2/2 MEFs using electroporation
protocols described above. Cells were blocked at S-phase by
exposure to 1 mM hydroxyurea (Sigma) for 24 h. Confocal
fluorescence microscopy (Leica TCS SP2 system) was used to
image the SHMT1-YFP fusion proteins at the Cornell Microscope
and Imaging Facility.
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